This article is more than 5 years old. Information may no longer be current.

NicOx reports Euro 13 million net loss for first quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SOPHIA ANTIPOLIS, France — NicOx reported a net loss of Euro 13 million for the first quarter, compared with a net profit of Euro 1.8 million for the first quarter of 2007, the company announced in a press release.

First-quarter revenues totaled Euro 1.4 million, compared with Euro 8.7 million for the same period last year. NicOx attributes this difference to two milestone payments from Merck & Co. and Pfizer, which were acknowledged in last year's first quarter.

NicOx's operating expenses totaled Euro 17.5 million for the first quarter, compared with Euro 10.1 million for the first quarter of 2007, according to the release.